Janus Henderson Group
VMD icon

Janus Henderson Group’s Viemed Healthcare VMD Stock Holding History

Janus Henderson Group’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,667
Closed -$74K – 1469
2019
Q3 		$74K Buy
+10,667
New +$71.1K ﹤0.01% 1393

Other funds holding VMD

CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Janus Henderson Group's VMD Position: Q4 2019 in Review

Janus Henderson Group sold out of Viemed Healthcare (VMD) in Q4 2019, closing a stake of 10,667 shares — an estimated $74K sold.

Janus Henderson Group first reported a position in VMD in Q3 2019 and held it in 1 quarter. The position peaked at $74K in Q3 2019. 41 funds tracked by Wall St. Rank hold VMD as of Q4 2019.

  • Janus Henderson Group reported no remaining Viemed Healthcare position as of Q4 2019 after selling out during the quarter.
  • Janus Henderson Group sold 10,667 Viemed Healthcare shares in Q4 2019, an estimated $74K.
  • Janus Henderson Group first reported a position in Viemed Healthcare in Q3 2019 and held it in 1 quarter.
  • Janus Henderson Group's Viemed Healthcare position peaked at $74K in Q3 2019.
  • 41 funds tracked by Wall St. Rank held Viemed Healthcare as of Q4 2019.

Based on Janus Henderson Group's 13F filing for Q4 2019, filed 18 Feb 2020.